227Th-Nanobody conjugate (Ablynx/Bayer)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name227Th-Nanobody conjugate (Ablynx/Bayer)
Drug Alias Name227Th-Nanobody conjugate (Ablynx/Algeta)227Thorium-Nanobody conjugate (Ablynx/Algeta)227Thorium-Nanobody conjugate (Ablynx/Bayer)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAblynx Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlgeta ASABayer AGAblynx Nv
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A